Stay updated on Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial

Sign up to get notified when there's something new on the Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-19T14:27:50.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-12T14:40:15.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The study record history adds a new revision entry (v3.7.0). The previous revision (v3.6.6) is removed from the list, reflecting an update to the page's version history.
    Difference
    0.1%
    Check dated 2026-09-21T20:12:56.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    A new Revision: v3.6.6 is added to the history and the previous Revision: v3.6.5 is removed. This reflects a minor update to the page's revision logs rather than any change to study content or user-facing features.
    Difference
    0.1%
    Check dated 2026-08-31T17:47:47.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    A new site revision (v3.6.5) was added to the version history, and the previous revision (v3.6.4) was removed. This updates the page’s historical record to reflect the latest release.
    Difference
    0.1%
    Check dated 2026-08-10T10:31:17.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    A new revision entry Revision: v3.6.4 was added to the study record history, replacing Revision: v3.6.3. This reflects a recent maintenance/update to the page rather than a change to study content.
    Difference
    0.1%
    Check dated 2026-07-27T06:18:59.000Z thumbnail image

Stay in the know with updates to Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial page.